EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 45.60
-1.40 (-2.98%)
At close: Apr 24, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 13.8 billion as of April 24, 2026. Its market cap has decreased by -41.47% in one year.
Market Cap
13.80B
Enterprise Value
11.98B
Revenue
1.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
45.60
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 13.80B, an increase of 202.81%. That is a compound annual growth rate of 12.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 13.80B | -26.08% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 25.35B |
| Lumosa Therapeutics | 21.77B |
| Sunmax Biotechnology | 21.46B |
| AP Biosciences | 17.67B |
| Medigen Vaccine Biologics | 15.83B |
| Polaris Group | 15.22B |
| TaiMed Biologics | 13.66B |
| Locus Cell | 13.08B |